Elite Pharma Stock Profit Margin
ELTPDelisted Stock | USD 0.04 0 6.75% |
Elite Pharma fundamentals help investors to digest information that contributes to Elite Pharma's financial success or failures. It also enables traders to predict the movement of Elite OTC Stock. The fundamental analysis module provides a way to measure Elite Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elite Pharma otc stock.
Elite |
Elite Pharma OTC Stock Profit Margin Analysis
Elite Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Elite Pharma Profit Margin | 0.20 % |
Most of Elite Pharma's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elite Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Elite Pharma has a Profit Margin of 0.1985%. This is 101.77% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 115.63% lower than that of the firm.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Elite Fundamentals
Return On Equity | 0.27 | ||||
Return On Asset | 0.0739 | ||||
Profit Margin | 0.20 % | ||||
Operating Margin | 0.15 % | ||||
Current Valuation | 27.92 M | ||||
Shares Outstanding | 1.01 B | ||||
Shares Owned By Insiders | 17.53 % | ||||
Shares Owned By Institutions | 0.06 % | ||||
Number Of Shares Shorted | 757.07 K | ||||
Price To Earning | 5.21 X | ||||
Price To Book | 1.12 X | ||||
Price To Sales | 0.92 X | ||||
Revenue | 32.26 M | ||||
Gross Profit | 14.8 M | ||||
EBITDA | 7.93 M | ||||
Net Income | 8.9 M | ||||
Cash And Equivalents | 19.78 M | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 1.39 M | ||||
Debt To Equity | 0.57 % | ||||
Current Ratio | 4.50 X | ||||
Book Value Per Share | 0.03 X | ||||
Cash Flow From Operations | 6.51 M | ||||
Short Ratio | 0.87 X | ||||
Earnings Per Share | 0.01 X | ||||
Target Price | 4.0 | ||||
Number Of Employees | 43 | ||||
Beta | 0.29 | ||||
Market Capitalization | 38.53 M | ||||
Total Asset | 35.15 M | ||||
Retained Earnings | (147.41 M) | ||||
Working Capital | 14.53 M | ||||
Current Asset | 19.66 M | ||||
Current Liabilities | 5.13 M | ||||
Z Score | 10.6 | ||||
Net Asset | 35.15 M |
About Elite Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elite Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elite Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elite Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Elite Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elite Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Elite OTC Stock
Moving against Elite OTC Stock
0.74 | EOLS | Evolus Inc | PairCorr |
0.68 | DRRX | Durect | PairCorr |
0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
0.68 | ACB | Aurora Cannabis | PairCorr |
0.67 | HLN | Haleon plc | PairCorr |
The ability to find closely correlated positions to Elite Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elite Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elite Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elite Pharma to buy it.
The correlation of Elite Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elite Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elite Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elite Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Managers Screen money managers from public funds and ETFs managed around the world |